Celltrion Holdings names J.P. Morgan as advisor

Published: 2013-05-27 06:57:00

Updated: 2013-05-27 06:57:00

Celltrion Holdings said Thursday it has signed an agreement with J.P. Morgan in move to help facilitate the sell-offs of Celltrion, Celltrion Healthcare Co. and Celltrion Pharm Inc to a multination drug firm.

Under the contract, J.P. Morgan will advise Celltrion Holdings on all the deals, whil...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK